[May 27] Spera Pharma to Host Webinar on "Basics of Microbiological Testing in Pharmaceutical QA and Latest CCIT Trends"
Spera Pharma will host a free online webinar on May 27, 2026, for pharmaceutical companies and research institutions titled "Basics of Microbiological Testing in Pharmaceutical QA and Latest CCIT Trends." Koichi Honjo will provide expert insights into testing requirements and practical CCIT procedures.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 00:00
- 🔍 Collected: May 26, 2026 at 15:31
- 🤖 AI Analyzed: May 26, 2026 at 16:00 (28 min after Collected)
Spera Pharma (Headquarters: Osaka, Japan; President: Keitaro Iwaki) will host a webinar on May 27, 2026, titled "Basics of Microbiological Testing in Pharmaceutical QA and Latest CCIT Trends."
■ About This Webinar
This webinar provides an overview of microbiological testing in pharmaceutical quality assurance, ranging from fundamental principles to the latest trends in Container Closure Integrity Testing (CCIT), an area of increasing importance. The session will organize the objectives and differences between microbial limit tests, sterility tests, and endotoxin tests, emphasizing the significance of suitability testing and reaction interference testing, along with practical considerations. The second half of the session will cover quantitative CCIT and microbial challenge testing based on regulatory trends, as well as the testing capabilities and equipment features available at Spera Pharma.
Recommended for:
- Researchers struggling to determine the scope of testing methods and condition settings for microbial limit tests, sterility tests, and endotoxin tests.
- Researchers who understand pharmacopeial requirements for suitability testing and reaction interference testing but are uncertain about practical implementation.
- Researchers looking to organize their approach to microbiological testing based on sample characteristics.
- Researchers wanting to understand the roles and integration of sterility evaluation via microbiological testing and CCIT.
- Researchers considering at what stage and which testing methods to consult or outsource to external experts based on the development phase.
■ Event Overview
Title: Basics of Microbiological Testing in Pharmaceutical QA and Latest CCIT Trends
Date and Time: Wednesday, May 27, 2026, 13:30–14:15
Format: Online (Microsoft Teams Webinar)
Participation Fee: Free
Registration: Please apply via the registration button below.
* This webinar is primarily intended for professionals in pharmaceutical companies and research institutions. Due to the nature of the content, participants from direct competitors may be declined.
* Program contents are subject to change without notice.
■ Speaker Profile
Koichi Honjo
Spera Pharma
Associate Director, Development & Analytical Research Laboratories, Osaka Research Center
After completing his Master's degree at Kyoto University Graduate School of Energy Science in 2003, Koichi Honjo joined Shimadzu Corporation, where he worked on contract services for gene and proteome analysis. In 2006, he moved to Chlorella Light Co., Ltd., where he was in charge of developing lactic acid bacteria beverages. In 2009, he joined Falco Biosystems Ltd., where he was involved in food and environmental microbial testing, as well as microbiological work related to pharmaceutical raw materials and regenerative medicine products. Since 2020, he has been with Spera Pharma, where he serves as a specialist in the microbiology field, providing technical support and handling pharmaceutical-related microbiological work.
■ About This Webinar
This webinar provides an overview of microbiological testing in pharmaceutical quality assurance, ranging from fundamental principles to the latest trends in Container Closure Integrity Testing (CCIT), an area of increasing importance. The session will organize the objectives and differences between microbial limit tests, sterility tests, and endotoxin tests, emphasizing the significance of suitability testing and reaction interference testing, along with practical considerations. The second half of the session will cover quantitative CCIT and microbial challenge testing based on regulatory trends, as well as the testing capabilities and equipment features available at Spera Pharma.
Recommended for:
- Researchers struggling to determine the scope of testing methods and condition settings for microbial limit tests, sterility tests, and endotoxin tests.
- Researchers who understand pharmacopeial requirements for suitability testing and reaction interference testing but are uncertain about practical implementation.
- Researchers looking to organize their approach to microbiological testing based on sample characteristics.
- Researchers wanting to understand the roles and integration of sterility evaluation via microbiological testing and CCIT.
- Researchers considering at what stage and which testing methods to consult or outsource to external experts based on the development phase.
■ Event Overview
Title: Basics of Microbiological Testing in Pharmaceutical QA and Latest CCIT Trends
Date and Time: Wednesday, May 27, 2026, 13:30–14:15
Format: Online (Microsoft Teams Webinar)
Participation Fee: Free
Registration: Please apply via the registration button below.
* This webinar is primarily intended for professionals in pharmaceutical companies and research institutions. Due to the nature of the content, participants from direct competitors may be declined.
* Program contents are subject to change without notice.
■ Speaker Profile
Koichi Honjo
Spera Pharma
Associate Director, Development & Analytical Research Laboratories, Osaka Research Center
After completing his Master's degree at Kyoto University Graduate School of Energy Science in 2003, Koichi Honjo joined Shimadzu Corporation, where he worked on contract services for gene and proteome analysis. In 2006, he moved to Chlorella Light Co., Ltd., where he was in charge of developing lactic acid bacteria beverages. In 2009, he joined Falco Biosystems Ltd., where he was involved in food and environmental microbial testing, as well as microbiological work related to pharmaceutical raw materials and regenerative medicine products. Since 2020, he has been with Spera Pharma, where he serves as a specialist in the microbiology field, providing technical support and handling pharmaceutical-related microbiological work.
FAQ
スペラファーマが開催するウェビナーのテーマは何ですか？
「医薬品の品質保証における微生物試験の基礎とCCITの最新動向」です。
このウェビナーはいつ開催されますか？
2026年5月27日（水）13:30から14:15まで開催されます。
ウェビナーの参加費用は必要ですか？
参加費用は無料です。
誰が登壇しますか？
スペラファーマ株式会社 大阪研究センター 開発分析研究所 アソシエイトディレクターの本庄弘一氏が登壇します。
このウェビナーは誰を対象としていますか？
製薬企業や研究機関の研究者を主な対象としています。